Overall AGTC gets a fundamental rating of 1 out of 10. We evaluated AGTC against 525 industry peers in the Biotechnology industry. AGTC may be in some trouble as it scores bad on both profitability and health. AGTC has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year AGTC has reported negative net income.
AGTC had a negative operating cash flow in the past year.

1.2 Ratios

AGTC's Return On Assets of -122.50% is on the low side compared to the rest of the industry. AGTC is outperformed by 85.05% of its industry peers.

		Industry Rank	Sector Rank
ROA	-122.5%
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AGTC so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AGTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGTC has more shares outstanding
AGTC has a worse debt/assets ratio than last year.

2.2 Solvency

AGTC has an Altman-Z score of -11.20. This is a bad value and indicates that AGTC is not financially healthy and even has some risk of bankruptcy.
AGTC's Altman-Z score of -11.20 is on the low side compared to the rest of the industry. AGTC is outperformed by 82.71% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that AGTC is not too dependend on debt financing.
The Debt to Equity ratio of AGTC (0.39) is worse than 85.36% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.39
Debt/FCF	N/A
Altman-Z	-11.2

ROIC/WACCN/A

WACC11.71%

2.3 Liquidity

A Current Ratio of 1.40 indicates that AGTC should not have too much problems paying its short term obligations.
The Current ratio of AGTC (1.40) is worse than 88.94% of its industry peers.
AGTC has a Quick Ratio of 1.40. This is a normal value and indicates that AGTC is financially healthy and should not expect problems in meeting its short term obligations.
AGTC has a worse Quick ratio (1.40) than 87.85% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.4
Quick Ratio	1.4

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AGTC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.48%, which is quite good.
The Revenue for AGTC has decreased by -35.00% in the past year. This is quite bad
Measured over the past years, AGTC shows a very negative growth in Revenue. The Revenue has been decreasing by -61.71% on average per year.

EPS 1Y (TTM)15.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%30%

Revenue 1Y (TTM)-35%

Revenue growth 3Y-80.17%

Revenue growth 5Y-61.71%

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AGTC will show a small growth in Earnings Per Share. The EPS will grow by 7.90% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y38.73%

EPS Next 2Y23.55%

EPS Next 3Y9.86%

EPS Next 5Y7.9%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AGTC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AGTC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.